U.S. FDA gives early approval to Sarepta's DMD gene therapy

U.S. FDA gives early approval to Sarepta's DMD gene therapy
Reuters: Health
The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's gene therapy for Duchenne muscular dystrophy (DMD).